Compare GOGO & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOGO | RLAY |
|---|---|---|
| Founded | 1991 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 941.0M | 1.0B |
| IPO Year | 2013 | 2020 |
| Metric | GOGO | RLAY |
|---|---|---|
| Price | $7.10 | $7.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $14.00 | ★ $16.00 |
| AVG Volume (30 Days) | 1.5M | ★ 2.1M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $817,729,000.00 | $8,355,000.00 |
| Revenue This Year | $107.81 | $20.47 |
| Revenue Next Year | $0.66 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 102.05 | N/A |
| 52 Week Low | $6.20 | $1.78 |
| 52 Week High | $16.82 | $8.36 |
| Indicator | GOGO | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 58.73 |
| Support Level | $6.99 | $7.23 |
| Resistance Level | $7.19 | $8.36 |
| Average True Range (ATR) | 0.29 | 0.51 |
| MACD | 0.08 | 0.05 |
| Stochastic Oscillator | 35.38 | 69.18 |
Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Gogo BA and Satcom Direct. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).